STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Aptargroup Stock Price, News & Analysis

ATR NYSE

Welcome to our dedicated page for Aptargroup news (Ticker: ATR), a resource for investors and traders seeking the latest updates and insights on Aptargroup stock.

AptarGroup, Inc. (ATR) delivers innovative dispensing systems and packaging solutions for pharmaceutical, beauty, and consumer goods markets worldwide. This page provides centralized access to official company announcements, financial updates, and industry developments.

Investors and stakeholders will find timely updates including earnings reports, product innovations, and strategic partnerships. Our curated news collection simplifies tracking regulatory milestones and market trends impacting AptarGroup's core segments: Pharma, Beauty, and Closures.

All content is sourced from verified corporate communications and reputable financial publications. Bookmark this page for efficient monitoring of ATR's operational developments, sustainability initiatives, and leadership changes within the global packaging industry.

News
Rhea-AI Summary

AptarGroup, Inc. (NYSE:ATR) reported an 8% increase in first-quarter 2021 sales, totaling $777 million. Core sales rose 1%, driven by strong demand in the Food + Beverage segment. Reported earnings per share jumped 48% to $1.24, boosted by a non-cash gain of $0.19 per share from an equity investment. Adjusted earnings per share increased 10% to $1.09. The company expects second-quarter EPS guidance between $0.91 to $0.99, reflecting ongoing challenges in prescription drug markets but optimistic long-term growth potential. A quarterly dividend was increased by 6% to $0.38 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
-
News
Rhea-AI Summary

AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.38 per share, representing a 6% increase from the previous dividend. The payment date is May 19, 2021, for stockholders of record as of April 28, 2021. In 2020, Aptar returned $93 million to shareholders and is set for its 28th consecutive year of increased annual dividends. The company achieved a Total Shareholder Return of 102% over the past five years, outperforming its peer group and the S&P Midcap 400.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.6%
Tags
dividends
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.2%
Tags
none
Rhea-AI Summary

AptarGroup, Inc. (NYSE:ATR) reported strong fourth quarter results with reported sales growing 12% to $749 million. Core sales increased 5%, driven by demand in Pharma and Food & Beverage segments. Earnings per share rose 8% to $0.79. For the year, reported sales grew 2% to $2.93 billion, but earnings per share fell 12% to $3.21 due to pandemic impacts. The company achieved record cash flow from operations of $570 million and declared a quarterly dividend of $0.36 per share, highlighting its commitment to shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.21%
Tags
-
Rhea-AI Summary

AptarGroup (NYSE: ATR) announces a partnership with CARE® to support global health initiatives, including the Fast + Fair COVID-19 Vaccine Response Campaign. This initiative aims to ensure equitable vaccine access for over 100 million people, focusing on women, impoverished communities, and healthcare workers across 10 countries. Aptar’s sponsorship emphasizes its commitment to diversity, inclusion, and women's empowerment, while aligning with its business model of producing vaccine delivery components. The collaboration promises to enhance CARE's efforts in advocating for equitable health policies worldwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.27%
Tags
partnership covid-19
-
Rhea-AI Summary

AptarGroup, Inc. (NYSE: ATR) has announced that its Activ-Film™ technology will protect a new SARS Rapid Antigen test for COVID-19, recently granted Emergency Use Authorization (EUA) by the FDA. This QuickVue® SARS Antigen test, developed by Quidel® Corporation, delivers results in just 10 minutes, enhancing access to affordable COVID-19 testing, especially in schools and rural areas. Activ-Film™ integrates material science to ensure test accuracy by protecting against moisture and environmental factors. Aptar is dedicated to providing critical healthcare solutions during the pandemic.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags
covid-19
Rhea-AI Summary

AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.36 per share, payable on February 17, 2021, to stockholders of record as of January 27, 2021. The company will also hold a conference call on February 19, 2021, at 8:00 a.m. Central Time to discuss its fourth quarter and year-end results for 2020. Additionally, the 2021 Annual Meeting of Stockholders will be held virtually on May 5, 2021, at 9:00 a.m. Central Time, with a record date for voting set for March 12, 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.44%
Tags
dividends
-
Rhea-AI Summary

AptarGroup, Inc. (NYSE: ATR) will participate in the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021, with a virtual presentation at 2:50 p.m. (EST) by key executives including President and CEO Stephan Tanda. A live webcast will be available in the Investors section of the Aptar website and a replay will be accessible for 90 days post-event. Aptar is a global leader in drug delivery and packaging solutions, headquartered in Crystal Lake, Illinois, employing 14,000 people across 19 countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.31%
Tags
conferences
-
Rhea-AI Summary

AptarGroup, Inc. (NYSE: ATR) has announced the schedule for its quarterly conference calls for 2021. Key dates include:

  • 4th Quarter and Annual Results: February 18, 2021 (Call on February 19, 2021, at 8:00 a.m. CT)
  • 1st Quarter 2021 Results: April 29, 2021 (Call on April 30, 2021, at 8:00 a.m. CT)
  • 2nd Quarter 2021 Results: July 29, 2021 (Call on July 30, 2021, at 8:00 a.m. CT)
  • 3rd Quarter 2021 Results: October 28, 2021 (Call on October 29, 2021, at 8:00 a.m. CT)

Press releases will be issued after the close of trading on NYSE.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.01%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.44%
Tags
none

FAQ

What is the current stock price of Aptargroup (ATR)?

The current stock price of Aptargroup (ATR) is $121.91 as of December 5, 2025.

What is the market cap of Aptargroup (ATR)?

The market cap of Aptargroup (ATR) is approximately 8.0B.
Aptargroup

NYSE:ATR

ATR Rankings

ATR Stock Data

8.01B
64.88M
1.07%
96.35%
1.43%
Medical Instruments & Supplies
Plastics Products, Nec
Link
United States
CRYSTAL LAKE